从2027年开始,医疗保险降低了包括Ozempic在内的15种高价药物的价格。 Medicare lowers prices for 15 high-cost drugs, including Ozempic, starting in 2027.

根据2027年生效的《降低通货膨胀法》药品价格谈判计划,医疗保健和医疗补助服务中心宣布降低15种高成本处方药的价格。 The Centers for Medicare and Medicaid Services announced lower prices for 15 high-cost prescription drugs under the Inflation Reduction Act’s Medicare drug price negotiation program, effective in 2027. Ozempic、Wegovy和Rybelsus等药物30天供应费用为274美元,低于959美元。 Drugs like Ozempic, Wegovy, and Rybelsus will cost $274 for a 30-day supply, down from $959. 削减额占2024年医疗保健计划D部分支出的15%,预计将节省120亿美元的纳税人费用和6.85亿美元的自付费用。 The cuts, covering 15% of Medicare Part D spending in 2024, are expected to save $12 billion in taxpayer costs and $685 million in out-of-pocket expenses. 该方案虽面临法律挑战,但仍然有效,它适用于治疗糖尿病、癌症、哮喘和其他疾病的药物。 The program, which has faced legal challenges but remains in effect, applies to drugs treating diabetes, cancer, asthma, and other conditions. 虽然有些价格高于单独的Trump-时代交易,但专家们认为,降低价格是解决药物负担能力问题方面取得的有意义的进展。 While some prices are higher than a separate Trump-era deal, experts view the reductions as meaningful progress in addressing drug affordability.